[go: up one dir, main page]

Larsén et al., 1972 - Google Patents

Association of sialic acid with microsomal membrane structures in rat liver

Larsén et al., 1972

Document ID
9160597575947796537
Author
Larsén C
Dallner G
Ernster L
Publication year
Publication venue
Biochemical and Biophysical Research Communications

External Links

Snippet

The amount of sialic acid on phospholipid basis increases from rough, through smooth II and smooth I microsomes, to Golgi membranes, all of them free from most of the adsorbed and luminal protein. The incorporation rate of glucosamine-3 H into sialic acid also follows a …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharide having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages

Similar Documents

Publication Publication Date Title
Ferrante et al. Induced degradation of glycosaminoglycans in Hurler's and Hunter's syndromes by plasma infusion
Paul et al. Preferential support of Ca2+ uptake in smooth muscle plasma membrane vesicles by an endogenous glycolytic cascade
Durand et al. Screening for metabolic syndrome application of a herring by-product hydrolysate after its separation by electrodialysis with ultrafiltration membrane and identification of novel anti-inflammatory peptides
Sando et al. Recognition and receptor-mediated uptake of a lysosomal enzyme, α-L-iduronidase, by cultured human fibroblasts
Davies Kinetics of icodextrin
Diamond The role of reactive oxygen species in animal models of glomerular disease
Blecher et al. Control of the metabolism and lipolytic effects of cyclic 3′, 5′-adenosine monophosphate in adipose tissue by insulin, methyl xanthines, and nicotinic acid
Larsén et al. Association of sialic acid with microsomal membrane structures in rat liver
Rösner et al. SIALIC ACID INCORPORATION INTO GANGLIOSIDES AND GLYCOPROTEINS OF THE FISH BRAIN 1
KR960007922B1 (en) Pasteurization of Tissue Protein PP4
Gaudreault et al. Erythrocyte membrane-bound daunorubicin as a delivery system in anticancer treatment
Christophe et al. Factors regulating biosynthesis, intracellular transport and secretion of amylase and lipase in the rat exocrine pancreas
Schuler et al. Glucocorticoid effect on hepatic carbohydrate metabolism in the endotoxin-shocked monkey
Urakami et al. Attenuation of ischemic liver injury by monoclonal anti-endothelin antibody, AwETN40
Yavin et al. Temperature‐mediated interaction of tetanus toxin with cerebral neuron cultures: characterization of a neuraminidase‐insensitive toxin‐receptor complex
Stout The effect of insulin on the incorporation of sodium (1-14C)-acetate into the lipids of the rat aorta
Kuo Stimulation of glucose utilization and inhibition of lipolysis by polyene antibiotics in isolated adipose cells
Mistry et al. Glucose polymer as an osmotic agent in CAPD
Shockley et al. New solutions for peritoneal dialysis in adult and pediatric patients
US6572855B1 (en) Use of hyaluronidase in the manufacturing of a drug for the treatment of inflammation
JP2583183B2 (en) Process for producing bioactive glycogen and bioactivity
Bouix et al. Protective effect of gamma-hydroxybutyrate and nicotinamide on low-dose streptozotocin-induced diabetes in mice
Doery et al. THE INTERACTION OF STAPHYLOCOCCAL TOXIN AND GANGLIOSIDE I. INACTIVATION OF THE LETHAL EFFECT OF STAPHYLOCOCCAL TOXIN IN MICE.
Ho et al. Lipase release induced by compound 48/80 in rat and perfused rat heart
CZ191098A3 (en) Process for preparing hyaluronidase and the use thereof